Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications

Author： Cracowski J.-L.   Durand T.   Bessard G.  

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.23, Iss.8, 2002-08, pp. : 360-366

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacology of Morphine in Obese Patients: Clinical Implications

By >   Declèves Xavier   >   Basdevant Arnaud   Clement Karine   Bardin Christophe  

Clinical Pharmacokinetics, Vol. 48, Iss. 10, 2009-10 ,pp. : 635-651

Adis International

Access to resources Recommend Favorite

Analgesics in Patients with Hepatic Impairment: Pharmacology and Clinical Implications

By Bosilkovska Marija  

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1645-1669

Adis International

Access to resources Recommend Favorite

The Isoprostanes - Unique Products of Arachidonate Peroxidation: Their Role as Mediators of Oxidant Stress

By  

Current Pharmaceutical Design, Vol. 12, Iss. 8, 2006-03 ,pp. : 895-902

Bentham Science Publishers

Access to resources Recommend Favorite

Nociceptin/Orphanin FQ Peptide Receptors: Pharmacology and Clinical Implications

By  

Current Drug Targets, Vol. 8, Iss. 1, 2007-01 ,pp. : 117-135

Bentham Science Publishers

Access to resources Recommend Favorite

Physiology and Pharmacology of the Vanilloid Receptor

By  

Current Neuropharmacology, Vol. 4, Iss. 1, 2006-01 ,pp. : 1-15

Bentham Science Publishers

Access to resources Recommend Favorite